Actinium Pharmaceuticals
ATNM
#10355
Rank
A$69.93 M
Marketcap
A$2.22
Share price
7.69%
Change (1 day)
8.75%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2026 (TTM): A$13.15 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are A$35.09 Million. In 2025 the company made an earning of -A$52.36 Million, an increase over its 2024 earnings that were of -A$60.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$13.15 M-125.13%
2025 -A$52.36 Million-13.95%
2024 -A$60.84 Million-18.87%
2023 -A$75 Million52.24%
2022 -A$49.26 Million36.61%
2021 -A$36.06 Million11.48%
2020 -A$32.35 Million1.46%
2019 -A$31.88 Million-7.37%
2018 -A$34.42 Million-11.46%
2017 -A$38.87 Million10.67%
2016 -A$35.13 Million15.7%
2015 -A$30.36 Million-14.86%
2014 -A$35.66 Million129.19%
2013 -A$15.56 Million-8.55%
2012 -A$17.02 Million
2010 A$0.01 M-152.15%
2009 -A$0.03 Million-39.8%
2008 -A$0.04 Million120.29%
2007 -A$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-A$53.72 Million-489.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$0.27 M-98.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.21 B 1,460.38%๐Ÿ‡บ๐Ÿ‡ธ USA